Global /New Zealand /Healthcare /Biotechnology /PHL
chevron_leftBack
Promisia Healthcare Ltd. logo

Promisia Healthcare Ltd.

PHL
NZE: PHL Delayed
0.4600NZD 0%
0.2651 USD
As of 12 July 2026, Promisia Healthcare Ltd. has a market cap of $13.99M USD, ranking #39450 globally and #100 in New Zealand. It ranks #3504 in the Healthcare sector, and #683 in the Biotechnology industry.
Global Rank
39450
1d: 0
1w: +40
1m: -
Country Rank
100
1d: 0
1w: 0
1m: -
Sector Rank
3504
1d: 0
1w: +14
1m: -
Industry Rank
683
1d: 0
1w: +4
1m: -
Key Stats
Market Cap
$13.99MUSD
24.29M NZD
Enterprise Value
$40.67MUSD
70.57M NZD
Revenue (TTM)
$21.41MUSD
37.18M NZD
EBITDA (TTM)
$1.96MUSD
3.4M NZD
Net Income (TTM)
$577.03KUSD
1.0M NZD
EBITDA Margin
9.1%
Profit Margin
2.7%
PE Ratio
22.5
PS Ratio
0.7
PB Ratio
0.6
EV/EBITDA
20.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Karen Lake open_in_new
Employees
418
Founded
1983
Website
promisia.co.nz open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% 3.4% -4.2% -6.1% 2.2% 19%

News

Loading...

Markets

Exchange Ticker Price
New Zealand Stock Exchange
MIC: XNZE
PRIMARY
PHL
Promisia Healthcare Ltd
ISIN: NZPRPE0001S5
Shares Out.:
52.82M1 Shares Float: 47.349M2
TV:
SA:
YF:
GF:
BA:
PHL
MS:
0.4600 NZD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Promisia Healthcare Ltd.

Promisia Healthcare Limited engages in the aged care and retirement living business in New Zealand. It offers a range of living options, such as rest home, dementia, respite, young disabled, palliative, and hospital care, as well as independent living options. The company was formerly known as Promisia Integrative Limited and changed its name to Promisia Healthcare Limited in February 2021. The company was incorporated in 1983 and is based in Wellington, New Zealand.

Similar Companies

Industry: Biotechnology (New Zealand)
Name
Market Cap diff.
PE
$100.12M
173.85M NZD
616%
-
$11.79M
20.47M NZD
-16%
21.9
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
AMGN
$182.42B
1M%
23.9
GILD
$159.92B
1M%
19.0
ARGX
$47.33B
41.39B EUR
338K%
39.9
$45.28B
68.19T KRW
324K%
35.5
CSL
$41.84B
60.27B AUD
299K%
29.3
LONN
$41.8B
33.71B CHF
299K%
37.2
chevron_leftBack